Bank of America Lowers Maravai LifeSciences (NASDAQ:MRVI) Price Target to $8.00
Maravai LifeSciences (NASDAQ:MRVI – Free Report) had its price objective cut by Bank of America from $9.00 to $8.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the stock. Several other research analysts also recently issued reports on MRVI. Baird R W downgraded shares of Maravai LifeSciences from […]
Maravai LifeSciences (NASDAQ:MRVI – Free Report) had its price objective cut by Bank of America from $9.00 to $8.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the stock. Several other research analysts also recently issued reports on MRVI. Baird R W downgraded shares of Maravai LifeSciences from […]
